FDA Panel Approves Arena’s lorcaserin

May 10th, 2012 by MorganDowney Leave a reply »

After a long day of discussing the significance of tumor development in rats taking lorcaserin, the FDA Endocrinologic and Metabolic Advisory Committee reversed a negative vote 2 years ago and have recommended approval by a vote of 18-4. FDA does not have to follow their recommendation but the FDA reviewers are satisfied that the drug has low risks. I expect they will approve it in the near future.

 

Leave a Reply

*